Clinical Trial Update: Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating mycophenolate mofetil in pediatric steroid-dependent nephrotic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Nephrotic Syndrome | Phase 4 | Status: COMPLETED